The Reducing Antipsychotics in People with Intellectual Disability (RAPID) project aims to reduce harm from antipsychotic medication prescribing to adults with intellectual disability.

Antipsychotic medications, designed to treat serious mental illness including schizophrenia, are often used for control of behaviour in people with intellectual disability.  This practice is largely unsupported by evidence, and associated with harm.  There is currently little research to inform service delivery on deprescribing antipsychotic and medications to Australians with intellectual disability. Inappropriate prescribing causes harm, so the proposed project will have a significant impact on the health and wellbeing of people with intellectual disability.

This is a pilot project to trial the efficacy of a protocol to reduce the inappropriate use of antipsychotic medications. 

The project is funded by the Endeavour Foundation Disability Research Fund.